Effects of omalizumab on eosinophil cationic peptide, 25-hydroxyvitamin-D, IL-1β and sCD200 in cases of Samter's syndrome: 36 months follow-up.
about
Aspirin-exacerbated respiratory disease: pathophysiological insights and clinical advancesEvaluation of soluble CD200 levels in type 2 diabetic foot and nephropathic patients: association with disease activityAn overview of the effects of anti-IgE therapies.Novel monoclonal treatments in severe asthma.Soluble CD200 Correlates With Interleukin-6 Levels in Sera of COPD Patients: Potential Implication of the CD200/CD200R Axis in the Disease Course.Advances in anti-IgE therapyThere might be a role for CD200 in the pathogenesis of autoimmune and inflammatory skin disorders.Omalizumab is effective in treating severe asthma in patients with severe cardiovascular complications and its effects on sCD200, d-dimer, CXCL8, 25-hydroxyvitamin D and IL-1β levels.Evaluation of d-dimer, CXCL8, homocysteine, eosinophil cationic peptide, 25(OH)-vitamin D and immunomodulatory OX-2 levels in allergic patients.
P2860
Q26750424-AA067186-D87E-4C0C-AAAA-BCDB10B436FFQ33856901-C1C75E9E-1764-4242-ABE3-6E0A7A04CDA7Q38252958-57B177F1-874E-4DA8-943C-76087952F3DEQ38911706-A77C2748-E56B-4169-9BD1-A19EE39287DAQ39172891-92F2ECBA-E4F1-4000-BE1C-3790A2053453Q40812061-B3A0F50F-A1DB-4646-BDF3-D1E0B5319F04Q41822047-B1505330-F86B-4DAC-B299-3113E6B1657DQ47943679-62A14643-D0CA-47D0-8DC5-F411326E5814Q51713013-37B219CD-644C-4D5E-93A8-F76C4F8E52AC
P2860
Effects of omalizumab on eosinophil cationic peptide, 25-hydroxyvitamin-D, IL-1β and sCD200 in cases of Samter's syndrome: 36 months follow-up.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Effects of omalizumab on eosin ...... syndrome: 36 months follow-up.
@en
Effects of omalizumab on eosin ...... syndrome: 36 months follow-up.
@nl
type
label
Effects of omalizumab on eosin ...... syndrome: 36 months follow-up.
@en
Effects of omalizumab on eosin ...... syndrome: 36 months follow-up.
@nl
prefLabel
Effects of omalizumab on eosin ...... syndrome: 36 months follow-up.
@en
Effects of omalizumab on eosin ...... syndrome: 36 months follow-up.
@nl
P2093
P2860
P1476
Effects of omalizumab on eosin ...... syndrome: 36 months follow-up.
@en
P2093
Ludwig G Strauss
Saadet Gumuslu
Seçil Uçar
P2860
P304
P356
10.3109/08923973.2013.811598
P577
2013-07-10T00:00:00Z